title: PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
authors.forename: Bob W
authors.initials: BW
authors.lastname: van Oosten
authors.forename: Joep
authors.initials: J
authors.lastname: Killestein
authors.forename: Frederik
authors.initials: F
authors.lastname: Barkhof
authors.forename: Chris H
authors.initials: CH
authors.lastname: Polman
authors.forename: Mike P
authors.initials: MP
authors.lastname: Wattjes
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069462:Dimethyl Fumarate; D004339:Drug Compounding; D005260:Female; D005650:Fumarates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D010291:Paresis / Q000139:chemically induced; D010594:Pharmacies; D011565:Psoriasis / Q000188:drug therapy
chemical_list: D003879:Dermatologic Agents; D005650:Fumarates; D000069462:Dimethyl Fumarate